Member Info for beinthelead

Belgrano - the company model, product and CEO are very good. It will be sustainably profitable.

To say there are traders out to get the price lower etc, if they don’t ramp things to high heaven is ridiculous. There’s no need to ramp - we’re here, we have a product.

Reality is, this stock is (and AIM) is erratic. The news is confirmatory, nothing more. Blue finish.

Belgrano - sell the news crew would have lost 6-7%. This isn’t the reason.

My guess is a blue finish. News not new, but solid and widely priced.

Fantastic update. Don’t underestimate the credibility of a CEO holding a date. Especially on AIM. Reassuring.

Not very well…

Not this again??

Nice to hear. Thanks.

Has Doggy’s ‘insider’ thread been taken down?

Doze: Yes. Maybe wasn’t clear.

We need a provider, I.e. won’t go it alone. But we’re not mandated to supply Medusa only.

They haven’t had to rely Medusa for this, before now, and struggled massively. Class leading product, very poor commercial execution.

So… Medusa is needed, not mandated.

This list could include 10,000 providers… they are distributers, in reality. The majority of the providers will be supplying the same test.

For AffiDX, USP to sell via this route is HUA. So for us, nothing’s changed.

We should be talking about what makes you choose a specific provider? Price - yes. But look at them all. Cheap through to expensive. And they’ll all sell.

Our USP will be Medusa. Marketing will be the differentiator. That list of 25 providers is very boring and bland. Nothing stands out.

Thanks roundhowe. Good call by the way :).

Probably dreaming - it’s been a long 12 months. But wasn’t this Chinese Medusa clone exposed last year?

Nearly as transparent as The Bishop (mortgage)

PAH00 - bang on. He forgets when Avacta put him right.

Assume this doesn’t include the undeclared lay user study samples??

Ndn - comments that were lies. That’s why people challenge your lunacy.

It’s not false. HUA is to be delivered.

AffiDX did not fail Porton Down.

Stop lying.

Wyn - so. Playing devils advocate, the LFT is a totally failure and only cancer stuff left to be concerned about.

Stop talking about it. You’re aiming to spook the concerned based on your nonsense.

Wyndrum. Sell.

No. It’s not Avacta’s decision. Do you not get this yet????

Also; how stable was the SP when AS decided to communicate CE submission and provide timescales? Didn’t work out too well, did it. And you for one criticised him for providing optimistic timescales.

Either take you money and go. Or just be quiet. You’re a virus.